Cardiovascular risk assessment using risk parameters including HDL and inflammatory biomarker interaction parameters

摘要

A cardiovascular risk assessment using risk parameters including HDL and inflammatory biomarker interaction parameters. Methods, systems and circuits evaluate a subject's CVD risk using at least one HDL and risk parameters including inflammatory biomarker interaction parameters. The inflammatory biomarker can optionally include an NMR-induced measurement of GlycA from at least one biosample of the subject. The risk parameter may be gender specific. [Selection diagram] Figure 1